urosphere

News & events

UROsphere and Vectalys selected by the SISMIP for their research programme « Discovery of new targets for prostatic pathologies»

The 3SI program for Innovation in the Health Sector is a call for innovative projects reserved to SMEs located in Midi-Pyrenees Region. This program is also supported by the Regional Board of OSEO (France's national agency for industrial innovation), the Regional Board for Research and Technology (DRRT), the Cancer-Bio-Health cluster and Midi Pyrénées Innovation (MPI). UROsphere and Vectalys (a company specialized in viral vector production and cell transduction expertises for gene discovery...

Urosphere receives a grant from OSEO Innovation.

UROsphere announces that OSEO Innovation has awarded a grant over a 2-year period to expand its experimental research platform for early stage drug development. The funding will be used to develop innovative in vivo and in vitro models to offer a wider range of assays for genitourinary pathologies. OSEO innovation (France's national agency for industrial innovation) funds innovative, technology-oriented projects for commercialization in France and abroad.

Urosphere targets genitourinary pathologies (FR)

UROsphere cible les pathologies génitourinaires. (Gazette du Laboratoire, Mai 2007) Spécialisée sur le marché de niche des pathologies de l'appareil urinaire, cette jeune entreprise innovante toulousaine développe ses propres molécules et propose des services (études pré-cliniques) à ses clients internationaux.  Article

“2007: an important year for Urosphere” (FR)

"2007 sera une année capitale pour UROsphere". (Biotech Finances, 19/02/07) En forte croissance depuis son essaimage, UROsphere doit franchir cette année un cap important. Article

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.